361 Capital’s Nu Skin NUS Stock Holding History

361 Capital’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-15,305	Closed	-$1.26M	–	378
2018 Q3	$1.26M	Buy	+15,305	New	+$1.22M	0.27%	212

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

361 Capital's NUS Position: Q4 2018 in Review

361 Capital sold out of Nu Skin (NUS) in Q4 2018, closing a stake of 15,305 shares — an estimated $1.26M sold.

361 Capital first reported a position in NUS in Q3 2018 and held it in 1 quarter. The position peaked at $1.26M in Q3 2018. 277 funds tracked by Wall St. Rank hold NUS as of Q4 2018.

361 Capital reported no remaining Nu Skin position as of Q4 2018 after selling out during the quarter.
361 Capital sold 15,305 Nu Skin shares in Q4 2018, an estimated $1.26M.
361 Capital first reported a position in Nu Skin in Q3 2018 and held it in 1 quarter.
361 Capital's Nu Skin position peaked at $1.26M in Q3 2018.
277 funds tracked by Wall St. Rank held Nu Skin as of Q4 2018.

Based on 361 Capital's 13F filing for Q4 2018, filed 8 Feb 2019.